(19)
(11) EP 1 740 183 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
25.11.2009 Bulletin 2009/48

(45) Mention of the grant of the patent:
14.10.2009 Bulletin 2009/42

(21) Application number: 05716901.3

(22) Date of filing: 03.03.2005
(51) International Patent Classification (IPC): 
A61K 31/519(2006.01)
A61K 31/5025(2006.01)
 A61K 31/53(2006.01)
A61P 25/00(2006.01)
(86) International application number:
PCT/EP2005/050958
(87) International publication number:
WO 2005/089766 (29.09.2005 Gazette 2005/39)

(54)

NOVEL USE FOR PDE5 INHIBITORS

NEUE VERWENDUNG VON PDE5-HEMMERN

NOUVELLE UTILISATION DES INHIBITEURS DE LA PDE5

(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU MC NL PL PT RO SE SI SK TR
Designated Extension States:
AL BA HR LV MK YU

(30) Priority: 05.03.2004 EP 04100909

(43) Date of publication of application:
10.01.2007 Bulletin 2007/02

(73) Proprietor: Nycomed GmbH
78467 Konstanz (DE)

(72) Inventors:
  • DUNKERN, Torsten
    78269 Volkertshausen (DE)
  • SCHUDT, Christian
    78462 Konstanz (DE)
  • GRIMMINGER, Friedrich
    35510 Butzbach (DE)
  • GHOFRANI, Ardeschir
    35398 Giessen (DE)
  • KAPS, Manfred
    35578 Wetzlar (DE)
  • ROSENGARTEN, Bernhard
    35398 Giessen (DE)

(74) Representative: Mechnich, Oliver M.J. et al
Nycomed GmbH Postfach 100310
78403 Konstanz
78403 Konstanz (DE)


(56) References cited: : 
EP-A- 0 985 671
WO-A-01/27112
WO-A-02/089808
 EP-A- 1 317 924
WO-A-98/38168
   
  • ZHANG RUILAN ET AL: "Nitric oxide enhances angiogenesis via the synthesis of vascular endothelial growth factor and cGMP after stroke in the rat." CIRCULATION RESEARCH. UNITED STATES 21 FEB 2003, vol. 92, no. 3, 21 February 2003 (2003-02-21), pages 308-313, XP002279004 ISSN: 1524-4571
   
Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).